The Yin and Yang of ERBB4: Tumor Suppressor and OncoproteinPHARMACOLOGICAL REVIEWSIF17.32022-01-0138OAAI
Targeting BRAF WT metastatic melanomas: Identifying ERBB4 mutations as biomarkers for novel combinatorial treatment strategiesCANCER RESEARCHIF16.62020-08-150PRE
Characterization of putative ErbB4 antagonists: targeted melanoma drug discoveryMOLECULAR CANCER THERAPEUTICSIF5.52018-01-010PRE